Search research articles
Contact Us
Filters
Showing results (1-10 of 41) with videos related to
Page
of 5
Sort By:
Plos Pathogens
|
October 27, 2010
High-resolution functional mapping of the venezuelan equine encephalitis virus genome by insertional mutagenesis and massively parallel sequencing
Brett F Beitzel, Russell R Bakken, Jeffrey M Smith, et al.
Antiviral Research
|
July 5, 2020
A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon
Kamal U Saikh, Elaine M Morazzani, Ashley E Piper, et al.
Scientific Reports
|
January 14, 2016
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses
Julia C Frei, Elisabeth K Nyakatura, Samantha E Zak, et al.
Immunology Letters
|
September 12, 2017
Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody
Daniel Hofmann, Samantha E Zak, Elisabeth K Nyakatura, et al.
Methods and Protocols
|
May 28, 2024
Syrian Hamsters Model Does Not Reflect Human-like Disease after Aerosol Exposure to Encephalitic Alphaviruses
Christina L Gardner, Rebecca A Erwin-Cohen, Bridget S Lewis, et al.
The Journal of Infectious Diseases
|
May 7, 2015
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease
Jennifer M Brannan, Jeffery W Froude, Laura I Prugar, et al.
Vaccine
|
May 1, 2016
1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus
Paridhi Gupta, Anuj Sharma, Kevin B Spurgers, et al.
Vaccine
|
November 17, 2009
Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB
Shannon S Martin, Russell R Bakken, Cathleen M Lind, et al.
Vaccine
|
March 3, 2010
Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus
Shannon S Martin, Russell R Bakken, Cathleen M Lind, et al.
Plos One
|
August 14, 2014
Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge
Shelley P Honnold, Russell R Bakken, Diana Fisher, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 41) with videos related to
Sort By:
Page
of 5
Plos Pathogens
|
October 27, 2010
High-resolution functional mapping of the venezuelan equine encephalitis virus genome by insertional mutagenesis and massively parallel sequencing
Brett F Beitzel, Russell R Bakken, Jeffrey M Smith, et al.
Antiviral Research
|
July 5, 2020
A small molecule inhibitor of MyD88 exhibits broad spectrum antiviral activity by up regulation of type I interferon
Kamal U Saikh, Elaine M Morazzani, Ashley E Piper, et al.
Scientific Reports
|
January 14, 2016
Bispecific Antibody Affords Complete Post-Exposure Protection of Mice from Both Ebola (Zaire) and Sudan Viruses
Julia C Frei, Elisabeth K Nyakatura, Samantha E Zak, et al.
Immunology Letters
|
September 12, 2017
Mechanistic and Fc requirements for inhibition of Sudan virus entry and in vivo protection by a synthetic antibody
Daniel Hofmann, Samantha E Zak, Elisabeth K Nyakatura, et al.
Methods and Protocols
|
May 28, 2024
Syrian Hamsters Model Does Not Reflect Human-like Disease after Aerosol Exposure to Encephalitic Alphaviruses
Christina L Gardner, Rebecca A Erwin-Cohen, Bridget S Lewis, et al.
The Journal of Infectious Diseases
|
May 7, 2015
Interferon α/β Receptor-Deficient Mice as a Model for Ebola Virus Disease
Jennifer M Brannan, Jeffery W Froude, Laura I Prugar, et al.
Vaccine
|
May 1, 2016
1,5-Iodonaphthyl azide-inactivated V3526 protects against aerosol challenge with virulent venezuelan equine encephalitis virus
Paridhi Gupta, Anuj Sharma, Kevin B Spurgers, et al.
Vaccine
|
November 17, 2009
Comparison of the immunological responses and efficacy of gamma-irradiated V3526 vaccine formulations against subcutaneous and aerosol challenge with Venezuelan equine encephalitis virus subtype IAB
Shannon S Martin, Russell R Bakken, Cathleen M Lind, et al.
Vaccine
|
March 3, 2010
Evaluation of formalin inactivated V3526 virus with adjuvant as a next generation vaccine candidate for Venezuelan equine encephalitis virus
Shannon S Martin, Russell R Bakken, Cathleen M Lind, et al.
Plos One
|
August 14, 2014
Second generation inactivated eastern equine encephalitis virus vaccine candidates protect mice against a lethal aerosol challenge
Shelley P Honnold, Russell R Bakken, Diana Fisher, et al.
Page
of 5